Meeting
2019 ASCO Quality Care Symposium
Visualizing treatment patterns and survival in metastatic breast cancer.
Authors
Aidan Gilbert
University of Alabama at Birmingham, Birmingham, AL
Aidan Gilbert, Courtney Williams, Pravinkumar Kandhare, Arie Nakhmani, Stephen C. Meersman, Elizabeth Garrett-Mayer, Melinda Kaltenbaugh, Andres Azuero, Stacey A. Ingram, Mark E. Burkard, Smita Bhatia, Kelly Kenzik, Gabrielle Betty Rocque
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care
Track
Patient Experience,Technology and Innovation in Quality of Care,Safety
Sub Track
Use of IT/Analytics to Improve Quality
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 316)
DOI
10.1200/JCO.2019.37.27_suppl.316
Abstract #
316
Poster Bd #
N5
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Disparities in treatment patterns and overall survival (OS) in hormone receptor-positive HER2+ metastatic breast cancer (MBC): A National Cancer Database Analysis.
First Author: Abby Statler
Poster
2022 ASCO Annual Meeting
Treatment patterns and their impact on the outcome of patients with HR+/HER2+ metastatic breast cancer in a large real-world cohort.
First Author: Marcela Carausu
Poster
2013 Breast Cancer Symposium
Hormone-receptor–positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer: Sequencing of chemotherapy and endocrine therapy.
First Author: Nicole M. Engel-Nitz
Poster
2013 ASCO Annual Meeting
Estimated life years saved with trastuzumab in first-line HER2+ metastatic breast cancer from 1999 to 2013.
First Author: Mark Danese